Pages that link to "Q40195749"

The following pages link to Histone deacetylase inhibitor enhances 5-fluorouracil cytotoxicity by down-regulating thymidylate synthase in human cancer cells (Q40195749):

Displaying 44 items.

• Altered histone modifications in gliomas (Q27027924) (← links)
• DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines. (Q30931932) (← links)
• Epigenetic mechanisms involved in differential MDR1 mRNA expression between gastric and colon cancer cell lines and rationales for clinical chemotherapy (Q33357010) (← links)
• Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors. (Q33390876) (← links)
• Cellular histone modification patterns predict prognosis and treatment response in resectable pancreatic adenocarcinoma: results from RTOG 9704. (Q33711106) (← links)
• Global proteome quantification for discovering imatinib-induced perturbation of multiple biological pathways in K562 human chronic myeloid leukemia cells (Q34283158) (← links)
• Expression of multidrug resistance proteins in invasive ductal carcinoma of the breast (Q34293229) (← links)
• Histone deacetylase inhibition synergistically enhances pemetrexed cytotoxicity through induction of apoptosis and autophagy in non-small cell lung cancer (Q34346813) (← links)
• Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylase. (Q34363544) (← links)
• Transcriptional activation and cell cycle block are the keys for 5-fluorouracil induced up-regulation of human thymidylate synthase expression (Q34443004) (← links)
• Histone/protein deacetylases control Foxp3 expression and the heat shock response of T-regulatory cells. (Q35300659) (← links)
• Chromosome segregation and organization are targets of 5'-Fluorouracil in eukaryotic cells (Q35497934) (← links)
• Use of mouse hematopoietic stem and progenitor cells to treat acute kidney injury (Q35652121) (← links)
• ERCC1 C118T associates with response to FOLFOX4 chemotherapy in colorectal cancer patients in Han Chinese (Q35929617) (← links)
• Effect of leucovorin on the antitumor efficacy of the 5-FU prodrug, tegafur-uracil, in human colorectal cancer xenografts with various expression levels of thymidylate synthase (Q36142392) (← links)
• Acquired resistance to 5-fluorouracil via HSP90/Src-mediated increase in thymidylate synthase expression in colon cancer (Q36544923) (← links)
• Histone deacetylases 6 and 9 and sirtuin-1 control Foxp3+ regulatory T cell function through shared and isoform-specific mechanisms. (Q36702713) (← links)
• Epigenetics and colorectal cancer pathogenesis (Q37061792) (← links)
• Treatment of pancreatic cancer: what can we really predict today? (Q37129815) (← links)
• Drug Insight: histone deacetylase inhibitor-based therapies for cutaneous T-cell lymphomas (Q37288403) (← links)
• Cancer pharmacoethnicity: ethnic differences in susceptibility to the effects of chemotherapy (Q37414536) (← links)
• Molecular epigenetics and genetics in neuro-oncology (Q37533620) (← links)
• Histone deacetylase inhibitors: current status and overview of recent clinical trials (Q37595483) (← links)
• HDAC Inhibitors and Cancer Therapy (Q37818093) (← links)
• The Role of HDACs as Leukemia Therapy Targets using HDI. (Q38341929) (← links)
• Combination of the histone deacetylase inhibitor depsipeptide and 5-fluorouracil upregulates major histocompatibility complex class II and p21 genes and activates caspase-3/7 in human colon cancer HCT-116 cells. (Q38443887) (← links)
• Novel MEK inhibitor trametinib and other retinoblastoma gene (RB)-reactivating agents enhance efficacy of 5-fluorouracil on human colon cancer cells (Q39189050) (← links)
• HSP90 inhibition induces cytotoxicity via down-regulation of Rad51 expression and DNA repair capacity in non-small cell lung cancer cells (Q39258864) (← links)
• CS055 (Chidamide/HBI-8000), a novel histone deacetylase inhibitor, induces G1 arrest, ROS-dependent apoptosis and differentiation in human leukaemia cells (Q39395916) (← links)
• Antitumor activity of NVP-AUY922, a novel heat shock protein 90 inhibitor, in human gastric cancer cells is mediated through proteasomal degradation of client proteins (Q39567800) (← links)
• Inhibition of Histone Deacetylase 10 Induces Thioredoxin-Interacting Protein and Causes Accumulation of Reactive Oxygen Species in SNU-620 Human Gastric Cancer Cells (Q39672379) (← links)
• Inhibition of histone deacetylase in cancer cells slows down replication forks, activates dormant origins, and induces DNA damage (Q39705077) (← links)
• Histone deacetylase inhibitors induce FPGS mRNA expression and intracellular accumulation of long-chain methotrexate polyglutamates in childhood acute lymphoblastic leukemia: implications for combination therapy (Q39752287) (← links)
• Histone acetylation resulting in resistance to methotrexate in choroid plexus cells (Q39929640) (← links)
• Effect of small interfering RNA 3'-end overhangs on chemosensitivity to thymidylate synthase inhibitors (Q42211322) (← links)
• Synergistic antitumor interaction between valproic acid, capecitabine and radiotherapy in colorectal cancer: critical role of p53. (Q46038047) (← links)
• Three Combined Treatments, a Novel HDAC Inhibitor OBP-801/YM753, 5-Fluorouracil, and Paclitaxel, Induce G₂ Phase Arrest Through the p38 Pathway in Human Ovarian Cancer Cells (Q48858994) (← links)
• Inhibition of polypyrimidine tract-binding protein 3 induces apoptosis and cell cycle arrest, and enhances the cytotoxicity of 5- fluorouracil in gastric cancer cells (Q50880824) (← links)
• Suberoylanilide hydroxamic acid enhances chemosensitivity to 5-fluorouracil in hepatocellular carcinoma via inhibition of thymidylate synthase. (Q52935211) (← links)
• Nucleobase and Nucleoside Analogues: Resistance and Re-Sensitisation at the Level of Pharmacokinetics, Pharmacodynamics and Metabolism (Q57175017) (← links)
• A phase I pharmacokinetic study of belinostat in patients with advanced cancers and varying degrees of liver dysfunction (Q91604096) (← links)
• HDACi mediate UNG2 depletion, dysregulated genomic uracil and altered expression of oncoproteins and tumor suppressors in B- and T-cell lines (Q91704713) (← links)
• Novel Strategies for Cancer Treatment: Highlights from the 55th IACR Annual Conference (Q92502884) (← links)
• Emerging roles of histone modifications and HDACs in RNA splicing (Q92513205) (← links)